Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

[(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.

Patra M, Ingram K, Pierroz V, Ferrari S, Spingler B, Gasser RB, Keiser J, Gasser G.

Chemistry. 2013 Feb 11;19(7):2232-5. doi: 10.1002/chem.201204291. Epub 2013 Jan 7.

PMID:
23296750
2.

Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.

Sadhu PS, Kumar SN, Chandrasekharam M, Pica-Mattoccia L, Cioli D, Rao VJ.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1103-6. doi: 10.1016/j.bmcl.2011.11.108. Epub 2011 Dec 13.

PMID:
22217873
3.

In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivatives.

Patra M, Ingram K, Leonidova A, Pierroz V, Ferrari S, Robertson MN, Todd MH, Keiser J, Gasser G.

J Med Chem. 2013 Nov 27;56(22):9192-8. doi: 10.1021/jm401287m. Epub 2013 Nov 12.

PMID:
24219617
4.

Praziquantel derivatives with antischistosomal activity: aromatic ring modification.

Wang ZX, Chen JL, Qiao C.

Chem Biol Drug Des. 2013 Aug;82(2):216-25. doi: 10.1111/cbdd.12153. Epub 2013 Jun 29.

PMID:
23617439
5.

Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.

Duan WW, Qiu SJ, Zhao Y, Sun H, Qiao C, Xia CM.

Bioorg Med Chem Lett. 2012 Feb 15;22(4):1587-90. doi: 10.1016/j.bmcl.2011.12.133. Epub 2012 Jan 4.

PMID:
22264473
7.

Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.

Yang JJ, Boissier J, Chen JL, Yao H, Yang S, Rognon A, Qiao C.

Future Med Chem. 2015;7(6):713-25. doi: 10.4155/fmc.15.20.

PMID:
25996065
8.

The anti-schistosomal drug praziquantel is an adenosine antagonist.

Angelucci F, Basso A, Bellelli A, Brunori M, Pica Mattoccia L, Valle C.

Parasitology. 2007 Aug;134(Pt 9):1215-21. Epub 2007 Apr 12.

PMID:
17428352
9.

Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation.

Patra M, Ingram K, Pierroz V, Ferrari S, Spingler B, Keiser J, Gasser G.

J Med Chem. 2012 Oct 25;55(20):8790-8. doi: 10.1021/jm301077m. Epub 2012 Oct 10.

PMID:
23005702
10.

(Ca(2+)-Mg2+)ATPase in Schistosoma mansoni: evidence for heterogeneity and resistance to praziquantel.

Cunha VM, Noël F.

Mem Inst Oswaldo Cruz. 1998;93 Suppl 1:181-2. No abstract available.

11.

Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes.

Khan MO, Keiser J, Amoyaw PN, Hossain MF, Vargas M, Le JG, Simpson NC, Roewe KD, Freeman TN, Hasley TR, Maples RD, Archibald SJ, Hubin TJ.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5331-6. doi: 10.1128/AAC.00778-16. Print 2016 Sep.

12.

Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.

Abo-Ghalia MH, Soliman AE.

Arzneimittelforschung. 1996 Feb;46(2):207-9.

PMID:
8720316
13.

Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni.

Cowan N, Yaremenko IA, Krylov IB, Terent'ev AO, Keiser J.

Bioorg Med Chem. 2015 Aug 15;23(16):5175-81. doi: 10.1016/j.bmc.2015.02.010. Epub 2015 Feb 14.

PMID:
25744189
14.

Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.

El-Bassiouni EA, Helmy MH, Saad EI, El-Nabi Kamel MA, Abdel-Meguid E, Hussein HS.

Br J Biomed Sci. 2007;64(4):168-74.

PMID:
18236739
15.

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL.

Am J Trop Med Hyg. 1999 Jun;60(6):932-5.

PMID:
10403323
16.

Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo.

Manneck T, Braissant O, Ellis W, Keiser J.

Exp Parasitol. 2011 Jan;127(1):260-9. doi: 10.1016/j.exppara.2010.08.011. Epub 2010 Aug 21.

PMID:
20732321
17.

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection.

Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Tanner M.

Trop Med Int Health. 2000 Nov;5(11):771-8.

18.

Praziquantel.

Cioli D, Pica-Mattoccia L.

Parasitol Res. 2003 Jun;90 Supp 1:S3-9. Epub 2002 Nov 22. Review.

PMID:
12811543
19.

Macromolecular bases of antischistosomal therapy.

Angelucci F, Miele AE, Boumis G, Brunori M, Dimastrogiovanni D, Bellelli A.

Curr Top Med Chem. 2011;11(16):2012-28. Review.

PMID:
21619508
20.

Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.

Drescher KM, Rogers EJ, Bruce JI, Katz N, Dias LC, Coles GC.

Mem Inst Oswaldo Cruz. 1993 Jan-Mar;88(1):89-95.

Supplemental Content

Support Center